Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

Research reports on PFO closure, mid-urethral slings, telehealth and more.

You may also be interested in...



RESPECT And PC Trial Results In, But Still No Real ‘Closure’ On PFO

There was some expectation leading up to TCT that the two trials could provide a definitive ruling on whether the PFO closure procedure had a future or not. But actual outcomes sparked a range of interpretations.

J&J/Ethicon Begins Worldwide Withdrawal Of Vaginal Mesh Products

Firm is stopping sales of four of its vaginal mesh products in the face of over 1,000 product liability lawsuits and FDA requirements for post-market safety and efficacy studies.

Case Closed On PFO Closure? A Principal Investigator Weighs In

Future prospects for devices that close patent foramen ovale heart defects to prevent recurrent strokes remain in some doubt as researchers continue to mull recent data.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031342

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel